Literature DB >> 17503465

Tyrosine-phosphorylated STAT5 accumulates on podosomes in Hck-transformed fibroblasts and chronic myeloid leukemia cells.

Renaud Poincloux1, Céline Cougoule, Thomas Daubon, Isabelle Maridonneau-Parini, Véronique Le Cabec.   

Abstract

In chronic myeloid leukemia (CML), the transforming activity of Bcr/Abl involves constitutive activation of the phagocyte specific Src-family tyrosine kinase Hck, which in turn directly activates the signal transducer and activator of transcription 5 (STAT5). The effect of Hck on STAT5 was first explored independently of Bcr/Abl by expressing the constitutively active Hck mutant (Hck(ca)) in MEF3T3-TetOff fibroblasts. As previously reported, Hck(ca)-expressing cells form podosomes which are actin-rich structures involved in trans-tissular cell migration and found in the few cell types able to cross anatomic boundaries. We demonstrated that in these cells, the tyrosine-phosphorylated form of STAT5 (PY-STAT5) increased and preferentially localized on podosomes together with Hck, instead of translocating to the nucleus as observed with conventional stimuli such as IFNgamma. To examine whether similar results were obtained in the presence of Bcr/Abl, the CML cell line K562 was used. We observed that (i) podosomal structures are present in these cells in contrast to Bcr/Abl-negative leukemic cells, (ii) podosome formation was inhibited by Bcr/Abl- and Src-kinase inhibitors, and (iii) PY-STAT5 mainly colocalized with Hck on these structures. The presence of podosomes was not sufficient to trap STAT5 since in normal macrophages which spontaneously form podosomes and express regulated Hck, PY-STAT5 is in the nucleus. In conclusion, this is the first report showing that PY-STAT5 associates to podosomes in a process dependent on constitutive activation of Hck. We propose that STAT5, previously classified as a transcription factor, could play another role outside the nucleus, elicited by the Bcr/Abl-Hck transforming pathway. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17503465     DOI: 10.1002/jcp.21112

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  12 in total

1.  Doubles game: Src-Stat3 versus p53-PTEN in cellular migration and invasion.

Authors:  Utpal K Mukhopadhyay; Patrick Mooney; Lilly Jia; Robert Eves; Leda Raptis; Alan S Mak
Journal:  Mol Cell Biol       Date:  2010-08-23       Impact factor: 4.272

2.  Three-dimensional migration of macrophages requires Hck for podosome organization and extracellular matrix proteolysis.

Authors:  Céline Cougoule; Véronique Le Cabec; Renaud Poincloux; Talal Al Saati; Jean-Louis Mège; Guillaume Tabouret; Clifford A Lowell; Nathalie Laviolette-Malirat; Isabelle Maridonneau-Parini
Journal:  Blood       Date:  2009-11-06       Impact factor: 22.113

3.  Macrophage mesenchymal migration requires podosome stabilization by filamin A.

Authors:  Romain Guiet; Christel Vérollet; Isabelle Lamsoul; Céline Cougoule; Renaud Poincloux; Arnaud Labrousse; David A Calderwood; Michael Glogauer; Pierre G Lutz; Isabelle Maridonneau-Parini
Journal:  J Biol Chem       Date:  2012-02-09       Impact factor: 5.157

4.  The podosome marker protein Tks5 regulates macrophage invasive behavior.

Authors:  Karen L Burger; Amanda L Davis; Scott Isom; Nilamadhab Mishra; Darren F Seals
Journal:  Cytoskeleton (Hoboken)       Date:  2011-11-08

5.  Podosomes and Invadopodia: Related structures with Common Protein Components that May Promote Breast Cancer Cellular Invasion.

Authors:  Daniel C Flynn; Youngjin Cho; Deanne Vincent; Jess M Cunnick
Journal:  Breast Cancer (Auckl)       Date:  2008-05-29

Review 6.  Leukaemia: a model metastatic disease.

Authors:  Andrew E Whiteley; Trevor T Price; Gaia Cantelli; Dorothy A Sipkins
Journal:  Nat Rev Cancer       Date:  2021-05-05       Impact factor: 69.800

Review 7.  Hematopoietic cell kinase (HCK) as a therapeutic target in immune and cancer cells.

Authors:  Ashleigh R Poh; Robert J J O'Donoghue; Matthias Ernst
Journal:  Oncotarget       Date:  2015-06-30

8.  Src family kinases interfere with dimerization of STAT5A through a phosphotyrosine-SH2 domain interaction.

Authors:  Dirk Fahrenkamp; Hildegard Schmitz-Van de Leur; Andrea Küster; Nicolas Chatain; Gerhard Müller-Newen
Journal:  Cell Commun Signal       Date:  2015-02-15       Impact factor: 5.712

9.  Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS.

Authors:  Serhiy Havrylov; Yuriy Rzhepetskyy; Agata Malinowska; Lyudmyla Drobot; Maria Jolanta Redowicz
Journal:  Proteome Sci       Date:  2009-06-16       Impact factor: 2.480

10.  Real-time monitoring of hematopoietic cell interaction with fibronectin fragment: the effect of histone deacetylase inhibitors.

Authors:  Adam Obr; Pavla Röselová; Dana Grebeňová; Kateřina Kuželová
Journal:  Cell Adh Migr       Date:  2013-04-08       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.